Editorials - page 15

Angiotensin receptor blockers in patients with heart failure and a reduced left ventricular ejection fraction. Implications of the HEAAL trial

Bertram Pitt

Pol Arch Intern Med. 2010, Vol. 120, No. 3: 68-70 / DOI: 10.20452/pamw.887

Increasing the dose of inhaled corticosteroid when asthma deteriorates – does it prevent severe exacerbations?

Helen K. Reddel

Pol Arch Intern Med. 2010, Vol. 120, No. 3: 64-67 / DOI: 10.20452/pamw.885

The role of the phosphodiesterase-4 inhibitor, roflumilast, in chronic obstructive pulmonary disease

Jadwiga A. Wedzicha

Pol Arch Intern Med. 2010, Vol. 120, No. 1-2: 9-10 / DOI: 10.20452/pamw.867

2009 update of the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction and guidelines on percutaneous coronary intervention. What should we change in clinical practice?

Spencer B. King III

Pol Arch Intern Med. 2010, Vol. 120, No. 1-2: 6-8 / DOI: 10.20452/pamw.865

The European Society of Cardiology 2009 guidelines on the prevention, diagnosis, and treatment of infective endocarditis. Key messages for clinical practice

James L. Harrison, Bernard D. Prendergast, Gilbert Habib

Pol Arch Intern Med. 2009, Vol. 119, No. 12: 773-776 / DOI: 10.20452/pamw.837

The use of inhaled anticholinergics in chronic obstructive pulmonary disease. Is there cause for concern of cardiovascular safety?

R. Andrew McIvor

Pol Arch Intern Med. 2009, Vol. 119, No. 11: 697-698 / DOI: 10.20452/pamw.813

Steroid use in critically ill septic patients: acknowledging the uncertainty

Roman Jaeschke, Gordon Guyatt

Pol Arch Intern Med. 2009, Vol. 119, No. 11: 694-696 / DOI: 10.20452/pamw.811

Inhibiting the renin‑angiotensin system in patients with type 1 diabetes: is it worth it?

Irena Duka, George Bakris

Pol Arch Intern Med. 2009, Vol. 119, No. 11: 692-693 / DOI: 10.20452/pamw.809

Does stenting for atherosclerotic renovascular disease improve blood pressure and kidney function better than medical treatment?

Pierre F. Plouin, Laurence Amar

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 612-613 / DOI: 10.20452/pamw.783

Antihypertensive treatment and dementia

Ingmar Skoog

Pol Arch Intern Med. 2009, Vol. 119, No. 9: 524-525 / DOI: 10.20452/pamw.757

American College of Cardiology/American Heart Association 2009 clinical guidelines for the diagnosis and management of heart failure in adults: update and clinical implications

Robin J. Trupp, William T. Abraham

Pol Arch Intern Med. 2009, Vol. 119, No. 7-8: 436-438 / DOI: 10.20452/pamw.731

Position paper of the Working Group of three Polish National Consultants in internal medicine, gastroenterology, and cardiology on prevention of gastrointestinal complications during antiplatelet treatment

Jacek Imiela, Grzegorz Opolski, Grażyna Rydzewska, Dorota Baczewska‑Mazurkiewicz, Robert Małecki, Krzysztof J. Filipiak

Pol Arch Intern Med. 2009, Vol. 119, No. 6: 347-348 / DOI: 10.20452/pamw.703

Lessons from the ACCOMPLISH trial

Joseph L. Izzo

Pol Arch Intern Med. 2009, Vol. 119, No. 6: 344-346 / DOI: 10.20452/pamw.701

The duration of deep vein thrombosis prophylaxis after major abdominal or pelvic surgery

David Bergqvist

Pol Arch Intern Med. 2009, Vol. 119, No. 4: 192-193 / DOI: 10.20452/pamw.648

2008 British guidelines on the management of interstitial lung diseases. What are the key new messages for clinical practice?

Howard M. Branley, Fiona R. Lake

Pol Arch Intern Med. 2009, Vol. 119, No. 3: 112-114 / DOI: 10.20452/pamw.622

Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?

Koon K. Teo

Pol Arch Intern Med. 2009, Vol. 119, No. 1-2: 8-10 / DOI: 10.20452/pamw.590

European Society of Cardiology practice guidelines on acute pulmonary embolism. An American’s commentary and personal perspectives

Samuel Z. Goldhaber

Pol Arch Intern Med. 2009, Vol. 119, No. 1-2: 6-7 / DOI: 10.20452/pamw.588

Updated European Guidelines on the management of acute myocardial infarction in patients presenting with ST‑segment elevation

Eric R. Bates

Pol Arch Intern Med. 2009, Vol. 119, No. 1-2: 4-5 / DOI: 10.20452/pamw.586

Osteoarthritis – a new sight?

Irena Zimmermann‑Górska

Pol Arch Intern Med. 2008, Vol. 118, Suppl. 1: 10-13 / DOI: 10.20452/pamw.556

Efficacy of diets in weight loss regimens: is the Mediterranean diet appropiate?

Lluís Serra‑Majem

Pol Arch Intern Med. 2008, Vol. 118, No. 12: 691-693 / DOI: 10.20452/pamw.528

previousof 18next

Impact Factor 2023

3.8

Quartile in the category

Q1

IC value for 2022

217.18

Ministry of Education and Science score

200
Average times from:
submission to 1st decision, 2 days
submission to first reviews, 24 days
acceptance to online first publication, 5 days
acceptance to final publication, 45 days

Current manuscript acceptance rate: 27%
The journal is co-financed from the state budget under the "Development of scientific journals" program of the Ministry of Education and Science in the years 2022-2024. Read more